Rezolute to Present Four Studies on Hyperinsulinism at Endocrine Society Meeting
Rezolute, Inc. will deliver one oral presentation and three poster presentations at the Endocrine Society annual meeting in Chicago from June 13-16, 2026. The presentations cover clinical trial results and outcomes data related to congenital and tumor-associated hyperinsulinism.
thehindu.comRezolute, Inc. announced four presentations scheduled for the Endocrine Society annual meeting, which runs June 13-16, 2026, in Chicago. One oral presentation will report top-line results from the global Phase 3 sunRIZE study of ersodetug in congenital hyperinsulinism.
m. CDT. Three poster presentations will address additional topics. One will describe a case series on compassionate use of ersodetug in patients with refractory hypoglycemia due to malignant insulin-secreting tumors. A second will examine the association between early-life hypoglycemia and later neurological outcomes using U.S. claims data.
The third will present a systematic review of outcomes in congenital hyperinsulinism.
The oral presentation is listed as SAT-10-06 in the Pediatric and Adolescent Endocrinology session. The three posters are scheduled for Saturday and Monday sessions covering neuroendocrinology, pediatric diabetes, and metabolic disorders. The company focuses on treatments for refractory hypoglycemia caused by congenital or acquired hyperinsulinism.
Transparency
Story details
Related Stories
BenzingaAmericans Paid $53 Billion Extra for Fuel Since Iran War Began, Democratic Senator Says
A Democratic senator stated that U.S. households have spent $53 billion more on gas and diesel since the Iran war started. Treasury officials described the added inflation as a short-term blip. A separate congressional committee put the extra cost at $43 billion.
ambcrypto.comCoinbase Launches Pre-IPO Perpetual Futures on SpaceX, Product Unavailable to U.S. Users
Coinbase introduced perpetual futures contracts tied to private companies, beginning with SpaceX. The contracts allow 24/7 price exposure outside the United States and will convert upon IPO completion.
insidermonkey.comCoronado Global Resources Director Resigns as Shareholders Approve 2026 Compensation Plan
Coronado Global Resources Inc. disclosed the resignation of a board member and the results of its annual shareholder vote. The changes trigger mandatory SEC disclosures and reset the board's composition for the company's next fiscal reporting cycle.